Avadel Pharmaceuticals PLC (AVDL)
13.88
-0.24
(-1.70%)
USD |
NASDAQ |
Jul 02, 16:00
14.16
+0.28
(+2.02%)
After-Hours: 17:46
Avadel Pharmaceuticals Research and Development Expense (Annual): 13.26M for Dec. 31, 2023
Research and Development Expense (Annual) Chart
Historical Research and Development Expense (Annual) Data
| Date | Value |
|---|---|
| December 31, 2023 | 13.26M |
| December 31, 2022 | 20.70M |
| December 31, 2021 | 17.10M |
| December 31, 2020 | 20.44M |
| December 31, 2019 | 32.92M |
| December 31, 2018 | 39.33M |
| December 31, 2017 | 33.42M |
| December 31, 2016 | 34.61M |
| December 31, 2015 | 25.61M |
| December 31, 2014 | 17.30M |
| December 31, 2013 | 15.97M |
| December 31, 2012 | 14.56M |
| December 31, 2011 | 25.09M |
| December 31, 2010 | 28.69M |
| Date | Value |
|---|---|
| December 31, 2009 | 30.42M |
| December 31, 2008 | 29.27M |
| December 31, 2007 | 43.56M |
| December 31, 2006 | 38.23M |
| December 31, 2005 | 47.30M |
| December 31, 2004 | 35.36M |
| December 31, 2003 | 20.22M |
| December 31, 2002 | 12.24M |
| December 31, 2001 | 10.66M |
| December 31, 2000 | 9.789M |
| December 31, 1999 | 11.05M |
| December 31, 1998 | 10.61M |
| December 31, 1997 | 10.10M |
R&D Expense Definition
R&D expense is a line item from many companies' income statements.
Research and Development Expense (Annual) Range, Past 5 Years
13.26M
Minimum
2023
32.92M
Maximum
2019
20.88M
Average
20.44M
Median
2020
Research and Development Expense (Annual) Benchmarks
| Trinity Biotech PLC | 4.379M |
| Amarin Corp PLC | 22.22M |
| Medtronic PLC | 2.735B |
| Biodexa Pharmaceuticals Plc | -- |
| Jazz Pharmaceuticals PLC | 849.66M |